{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T01:57:45Z","timestamp":1776995865299,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T00:00:00Z","timestamp":1439424000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12882-015-0139-9","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T11:21:51Z","timestamp":1439378511000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study"],"prefix":"10.1186","volume":"16","author":[{"given":"Paraish S.","family":"Misra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahsan","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark L.","family":"Lipman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon J.","family":"Nessim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,13]]},"reference":[{"key":"139_CR1","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMc066308","volume":"355","author":"M Epstein","year":"2006","unstructured":"Epstein M, McGrath S, Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med. 2006;355:1834\u20136.","journal-title":"N Engl J Med"},{"key":"139_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1365-2265.2008.03194.x","volume":"69","author":"T Cundy","year":"2008","unstructured":"Cundy T, Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf). 2008;69:338\u201341.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"139_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","volume":"56","author":"EJ Hoorn","year":"2010","unstructured":"Hoorn EJ, van der Hoek J, de Man RA, Kuipers EJ, Bolwerk C, Zietse R. A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis. 2010;56:112\u20136.","journal-title":"Am J Kidney Dis"},{"key":"139_CR4","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1053\/j.ajkd.2010.03.013","volume":"56","author":"G Regolisti","year":"2010","unstructured":"Regolisti G, Cabassi A, Parenti E, Maggiore U, Fiaccadori E. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor. Am J Kidney Dis. 2010;56:168\u201374.","journal-title":"Am J Kidney Dis"},{"key":"139_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/qjmed\/hcq021","volume":"103","author":"JD Mackay","year":"2010","unstructured":"Mackay JD, Bladon PT. Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series. QJM. 2010;103:387\u201395.","journal-title":"QJM"},{"key":"139_CR6","doi-asserted-by":"crossref","unstructured":"Krupa LZ, Fellows IW. Lansoprazole-induced hypomagnesaemia. BMJ Case Rep 2014;2014.","DOI":"10.1136\/bcr-2012-006342"},{"key":"139_CR7","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/ki.2012.452","volume":"83","author":"J Danziger","year":"2013","unstructured":"Danziger J, William JH, Scott DJ, Lee J,\u00a0Lehman LW,\u00a0Mark RG, et al. Proton-pump inhibitor use is associated with low serum magnesium concentrations. Kidney Int. 2013;83:692\u20139.","journal-title":"Kidney Int"},{"key":"139_CR8","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/pds.3224","volume":"21","author":"JT Gau","year":"2012","unstructured":"Gau JT, Yang YX, Chen R, Kao TC. Uses of proton pump inhibitors and hypomagnesemia. Pharmacoepidemiol Drug Saf. 2012;21:553\u20139.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"139_CR9","doi-asserted-by":"publisher","first-page":"e1001736","DOI":"10.1371\/journal.pmed.1001736","volume":"11","author":"J Zipursky","year":"2014","unstructured":"Zipursky J, Macdonald EM, Hollands S, Gomes T,\u00a0Mamdani MM,\u00a0Paterson JM,\u00a0et al. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case\u2013control study. PLoS Med. 2014;11:e1001736.","journal-title":"PLoS Med"},{"key":"139_CR10","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1159\/000360011","volume":"39","author":"M Alhosaini","year":"2014","unstructured":"Alhosaini M, Walter JS, Singh S, Dieter RS, Hsieh A, Leehey DJ. Hypomagnesemia in hemodialysis patients: role of proton pump inhibitors. Am J Nephrol. 2014;39:204\u20139.","journal-title":"Am J Nephrol"},{"key":"139_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1053\/j.ajkd.2013.02.373","volume":"62","author":"I Koulouridis","year":"2013","unstructured":"Koulouridis I, Alfayez M, Tighiouart H, Madias NE, Kent DM, Paulus JK, et al. Out-of-hospital use of proton pump inhibitors and hypomagnesemia at hospital admission: a nested case\u2013control study. Am J Kidney Dis. 2013;62:730\u20137.","journal-title":"Am J Kidney Dis"},{"key":"139_CR12","doi-asserted-by":"crossref","unstructured":"Van Ende C, Van Laecke S, Marechal C, \u00a0Verbeke F,\u00a0Kanaan N,\u00a0Goffin E,\u00a0et al. Proton-pump inhibitors do not influence serum magnesium levels in renal transplant recipients. J Nephrol 2014.","DOI":"10.1007\/s40620-014-0105-9"},{"key":"139_CR13","doi-asserted-by":"crossref","unstructured":"Lindner G, Funk GC, Leichtle AB, Fiedler GM,\u00a0Schwarz C,\u00a0Eleftheriadis T,\u00a0et al. Impact of proton pump inhibitor use on magnesium homoeostasis: a cross-sectional study in a tertiary emergency department. Int J Clin Pract 2014.","DOI":"10.1111\/ijcp.12469"},{"key":"139_CR14","doi-asserted-by":"crossref","unstructured":"Markovits N, Loebstein R, Halkin H, Bialik M,\u00a0Landes-Westerman J,\u00a0Lomnicky J,\u00a0et al. The association of proton pump inhibitors and hypomagnesemia in the community setting. J Clin Pharmacol. 2014;54:889\u201395.","DOI":"10.1002\/jcph.316"},{"key":"139_CR15","doi-asserted-by":"crossref","unstructured":"Schlingmann KP, Weber S, Peters M, Niemann Nejsum L,\u00a0Vitzthum H,\u00a0Klingel K,\u00a0et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet. 2002;31:166\u201370.","DOI":"10.1038\/ng889"},{"key":"139_CR16","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1021\/mp300323q","volume":"9","author":"JP Bai","year":"2012","unstructured":"Bai JP, Hausman E, Lionberger R, Zhang X. Modeling and simulation of the effect of proton pump inhibitors on magnesium homeostasis. 1. Oral absorption of magnesium. Mol Pharm. 2012;9:3495\u2013505.","journal-title":"Mol Pharm"},{"key":"139_CR17","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3748\/wjg.v17.i12.1574","volume":"17","author":"N Thongon","year":"2011","unstructured":"Thongon N, Krishnamra N. Omeprazole decreases magnesium transport across Caco-2 monolayers. World J Gastroenterol. 2011;17:1574\u201383.","journal-title":"World J Gastroenterol"},{"key":"139_CR18","doi-asserted-by":"publisher","first-page":"684","DOI":"10.3858\/emm.2012.44.11.077","volume":"44","author":"N Thongon","year":"2012","unstructured":"Thongon N, Krishnamra N. Apical acidity decreases inhibitory effect of omeprazole on Mg(2+) absorption and claudin-7 and \u221212 expression in Caco-2 monolayers. Exp Mol Med. 2012;44:684\u201393.","journal-title":"Exp Mol Med"},{"key":"139_CR19","volume-title":"Danziger J","author":"JH William","year":"2014","unstructured":"William JH, Nelson R, Hayman N, Mukamal KJ. Danziger J. Nephrology (Carlton): Proton-Pump Inhibitor use is associated with lower Urinary Magnesium Excretion; 2014."},{"key":"139_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0272-6386(99)70106-X","volume":"34","author":"JF Navarro","year":"1999","unstructured":"Navarro JF, Mora C, Jimenez A, Torres A, Macia M, Garcia J. Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients. Am J Kidney Dis. 1999;34:43\u20138.","journal-title":"Am J Kidney Dis"},{"key":"139_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1053\/ajkd.2002.33398","volume":"39","author":"JY Guh","year":"2002","unstructured":"Guh JY, Chen HC, Chuang HY, Huang SC, Chien LC, Lai YH. Risk factors and risk for mortality of mild hypoparathyroidism in hemodialysis patients. Am J Kidney Dis. 2002;39:1245\u201354.","journal-title":"Am J Kidney Dis"},{"key":"139_CR22","doi-asserted-by":"crossref","unstructured":"Gohda T, Shou I, Fukui M, Funabiki K,\u00a0Horikoshi S,\u00a0Shirato I,\u00a0et al. Parathyroid hormone gene polymorphism and secondary hyperparathyroidism in hemodialysis patients. Am J Kidney Dis. 2002;39:1255\u201360.","DOI":"10.1053\/ajkd.2002.33399"},{"key":"139_CR23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/089686089901900509","volume":"19","author":"JF Navarro","year":"1999","unstructured":"Navarro JF, Mora C, Macia M, Garcia J. Serum magnesium concentration is an independent predictor of parathyroid hormone levels in peritoneal dialysis patients. Perit Dial Int. 1999;19:455\u201361.","journal-title":"Perit Dial Int"},{"key":"139_CR24","doi-asserted-by":"crossref","unstructured":"Cho MS, Lee KS, Lee YK, Ma SK,\u00a0Ko JH,\u00a0Kim SW,\u00a0et al. Relationship between the serum parathyroid hormone and magnesium levels in continuous ambulatory peritoneal dialysis (CAPD) patients using low-magnesium peritoneal dialysate. Korean J Intern Med. 2002;17:114\u201321.","DOI":"10.3904\/kjim.2002.17.2.114"},{"key":"139_CR25","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/ndt\/gfs520","volume":"28","author":"L Louvet","year":"2013","unstructured":"Louvet L, Buchel J, Steppan S, Passlick-Deetjen J, Massy ZA. Magnesium prevents phosphate-induced calcification in human aortic vascular smooth muscle cells. Nephrol Dial Transplant. 2013;28:869\u201378.","journal-title":"Nephrol Dial Transplant"},{"key":"139_CR26","doi-asserted-by":"crossref","unstructured":"Kircelli F, Peter ME, Sevinc Ok E, Celenk FG,\u00a0Yilmaz M,\u00a0Steppan S,\u00a0et al. Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner. Nephrol Dial Transplant. 2012;27:514\u201321.","DOI":"10.1093\/ndt\/gfr321"},{"key":"139_CR27","doi-asserted-by":"crossref","unstructured":"Ishimura E, Okuno S, Kitatani K, Tsuchida T,\u00a0Yamakawa T,\u00a0Shioi A,\u00a0et al. Significant association between the presence of peripheral vascular calcification and lower serum magnesium in hemodialysis patients. Clin Nephrol. 2007;68:222\u20137.","DOI":"10.5414\/CNP68222"},{"key":"139_CR28","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/ki.1987.222","volume":"32","author":"HE Meema","year":"1987","unstructured":"Meema HE, Oreopoulos DG, Rapoport A. Serum magnesium level and arterial calcification in end-stage renal disease. Kidney Int. 1987;32:388\u201394.","journal-title":"Kidney Int"},{"key":"139_CR29","unstructured":"Tzanakis I, Virvidakis K, Tsomi A, Mantakas E,\u00a0Girousis N,\u00a0Karefyllakis N,\u00a0et al. Intra- and extracellular magnesium levels and atheromatosis in haemodialysis patients. Magnes Res. 2004;17:102\u20138."},{"key":"139_CR30","doi-asserted-by":"crossref","unstructured":"Tzanakis I, Pras A, Kounali D, Mamali V,\u00a0Kartsonakis V,\u00a0Mayopoulou-Symvoulidou D,\u00a0et al. Mitral annular calcifications in haemodialysis patients: a possible protective role of magnesium. Nephrol Dial Transplant. 1997;12:2036\u20137.","DOI":"10.1093\/ndt\/12.9.2036"},{"key":"139_CR31","doi-asserted-by":"crossref","unstructured":"Tzanakis IP, Stamataki EE, Papadaki AN, Giannakis N, Damianakis NE, Oreopoulos DG. Magnesium retards the progress of the arterial calcifications in hemodialysis patients: a pilot study. Int Urol Nephrol. 2014.","DOI":"10.1007\/s11255-014-0751-9"},{"key":"139_CR32","first-page":"237","volume":"20","author":"E Ishimura","year":"2007","unstructured":"Ishimura E, Okuno S, Yamakawa T, Inaba M, Nishizawa Y. Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients. Magnes Res. 2007;20:237\u201344.","journal-title":"Magnes Res"},{"key":"139_CR33","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/ki.2013.327","volume":"85","author":"Y Sakaguchi","year":"2014","unstructured":"Sakaguchi Y, Fujii N, Shoji T, Hayashi T, Rakugi H, Isaka Y. Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis. Kidney Int. 2014;85:174\u201381.","journal-title":"Kidney Int"},{"key":"139_CR34","doi-asserted-by":"crossref","unstructured":"Moist LM, Port FK, Orzol SM, Young EW,\u00a0Ostbye T,\u00a0Wolfe RA,\u00a0et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol. 2000;11:556\u201364.","DOI":"10.1681\/ASN.V113556"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-015-0139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12882-015-0139-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-015-0139-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T08:10:53Z","timestamp":1653034253000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-015-0139-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["139"],"URL":"https:\/\/doi.org\/10.1186\/s12882-015-0139-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,13]]},"article-number":"136"}}